Exagen (XGN) Short Interest Ratio & Short Volume $6.60 +0.57 (+9.45%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$6.73 +0.13 (+1.97%) As of 05/23/2025 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Exagen Short Interest DataExagen (XGN) has a short interest of 90,500 shares, representing 0.98% of the float (the number of shares available for trading by the public). This marks a 48.85% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 114,676 shares to cover all short positions.Current Short Interest90,500 sharesPrevious Short Interest60,800 sharesChange Vs. Previous Month+48.85%Dollar Volume Sold Short$563,815.00Short Interest Ratio0.6 Days to CoverLast Record DateApril 30, 2025Outstanding Shares21,300,000 sharesFloat Size9,220,000 sharesShort Percent of Float0.98%Today's Trading Volume600,762 sharesAverage Trading Volume114,676 sharesToday's Volume Vs. Average524% Short Selling Exagen? Sign up to receive the latest short interest report for Exagen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXGN Short Interest Over TimeXGN Days to Cover Over TimeXGN Percentage of Float Shorted Over Time Exagen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202590,500 shares $563,815.00 +48.9%1.0%0.6 $6.23 4/15/202560,800 shares $268,128.00 +31.6%0.7%0.5 $4.41 3/31/202546,200 shares $165,858.00 +162.5%0.5%0.3 $3.59 3/15/202517,600 shares $62,656.00 -23.5%0.2%0.1 $3.56 2/28/202523,000 shares $79,580.00 -29.2%0.3%0.1 $3.46 2/15/202532,500 shares $137,475.00 +21.7%0.4%0.2 $4.23 1/31/202526,700 shares $106,800.00 +260.8%0.3%0.2 $4.00 1/15/20257,400 shares $23,088.00 -90.7%0.1%0.1 $3.12 12/31/202479,200 shares $324,720.00 +1.4%0.9%0.7 $4.10 12/15/202478,100 shares $451,027.50 +36.5%0.9%1 $5.78 Get the Latest News and Ratings for XGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exagen and its competitors with MarketBeat's FREE daily newsletter. 11/30/202457,200 shares $227,084.00 -9.1%0.7%1.2 $3.97 11/15/202462,900 shares $187,442.00 +20.5%0.8%1.4 $2.98 10/31/202452,200 shares $126,846.00 +122.1%0.6%1.4 $2.43 10/15/202423,500 shares $63,450.00 +48.7%0.3%0.4 $2.70 9/30/202415,800 shares $48,822.00 -6.0%0.2%0.3 $3.09 9/15/202416,800 shares $49,728.00 +20.9%0.2%0.3 $2.96 8/31/202413,900 shares $41,422.00 -12.0%0.2%0.3 $2.98 8/15/202415,800 shares $44,714.00 -41.5%0.2%0.3 $2.83 7/31/202427,000 shares $52,650.00 -7.2%0.3%0.5 $1.95 7/15/202429,100 shares $57,618.00 -22.2%0.3%0.8 $1.98 6/30/202437,400 shares $68,068.00 +67.7%0.4%1.1 $1.82 6/15/202422,300 shares $43,708.00 -7.5%0.3%0.6 $1.96 5/31/202424,100 shares $46,995.00 -14.8%0.3%0.5 $1.95 5/15/202428,300 shares $54,053.00 +573.8%0.3%0.6 $1.91 4/30/20244,200 shares $5,754.00 -64.7%0.1%0.1 $1.37 4/15/202411,900 shares $17,017.00 -42.0%0.2%0.3 $1.43 3/31/202420,500 shares $32,595.00 +294.2%0.3%0.5 $1.59 3/15/20245,200 shares $8,424.00 +20.9%0.1%0.1 $1.62 2/29/20244,300 shares $9,675.00 -35.8%0.1%0.1 $2.25 2/15/20246,700 shares $14,137.00 -39.1%0.1%0.1 $2.11 1/31/202411,000 shares $23,650.00 +32.5%0.1%0.2 $2.15 1/15/20248,300 shares $16,600.00 -65.7%0.1%0.2 $2.00 12/31/202324,200 shares $48,158.00 +633.3%0.3%0.5 $1.99 12/15/20233,300 shares $5,115.00 -65.6%0.0%0.1 $1.55 11/30/20239,600 shares $18,048.00 +28.0%0.1%0.3 $1.88 11/15/20237,500 shares $11,586.00 +4.2%0.1%0.4 $1.54 10/31/20237,200 shares $11,808.00 +24.1%0.1%0.6 $1.64 10/15/20235,800 shares $10,904.00 -45.3%0.1%0.4 $1.88 9/30/202310,600 shares $25,652.00 -14.5%0.1%0.7 $2.42 9/15/202312,400 shares $30,132.00 +27.8%0.2%0.8 $2.43$19 for a FULL YEAR of stock picks?! (Ad)Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.Watch the exclusive AI investor briefing >>> 8/31/20239,700 shares $24,444.00 -17.8%0.1%0.6 $2.52 8/15/202311,800 shares $29,500.00 +81.5%0.1%0.8 $2.50 7/31/20236,500 shares $15,990.00 -38.7%0.1%0.3 $2.46 7/15/202310,600 shares $28,620.00 +39.5%0.1%0.6 $2.70 6/30/20237,600 shares $22,040.00 +8.6%0.1%0.5 $2.90 6/15/20237,000 shares $22,540.00 -42.2%0.1%0.4 $3.22 5/31/202312,100 shares $36,421.00 +72.9%0.1%0.6 $3.01 5/15/20237,000 shares $20,370.00 -54.6%0.1%0.3 $2.91 4/30/202315,400 shares $39,116.00 +75.0%0.2%0.9 $2.54 4/15/20238,800 shares $21,384.00 +8.6%0.1%0.5 $2.43 3/31/20238,100 shares $19,683.00 -16.5%0.1%0.4 $2.43 3/15/20239,700 shares $22,989.00 -54.9%0.1%0.4 $2.37 2/28/202321,500 shares $54,825.00 +32.7%0.2%0.8 $2.55 2/15/202316,200 shares $40,824.00 -22.1%0.2%0.3 $2.52 1/31/202320,800 shares $59,072.00 -64.0%0.2%0.2 $2.84 1/15/202357,800 shares $167,042.00 -20.4%0.6%0.6 $2.89 12/30/202272,600 shares $174,240.00 -30.1%0.7%0.8 $2.40 12/15/2022103,900 shares $257,672.00 +3.5%1.1%1.1 $2.48 11/30/2022100,400 shares $271,080.00 +666.4%1.0%1.1 $2.70 11/15/202213,100 shares $39,169.00 -34.8%0.1%0.2 $2.99 10/31/202220,100 shares $49,245.00 -33.7%0.2%0.7 $2.45 10/15/202230,300 shares $73,629.00 -14.2%0.3%1.6 $2.43 9/30/202235,300 shares $95,663.00 +18.5%0.4%1.6 $2.71 9/15/202229,800 shares $141,252.00 -18.4%0.3%0.7 $4.74 8/31/202236,500 shares $165,345.00 -5.7%0.4%0.8 $4.53 8/15/202238,700 shares $195,435.00 -14.8%0.4%0.7 $5.05 7/31/202245,400 shares $335,506.00 -25.2%0.5%0.8 $7.39 7/15/202260,700 shares $449,180.00 -23.7%0.7%0.9 $7.40 6/30/202279,600 shares $456,904.00 -79.5%0.9%1.2 $5.74 6/15/2022387,600 shares $2.37 million -4.1%4.2%6 $6.12 5/31/2022404,100 shares $2.02 million +5.0%4.4%8.6 $5.00 5/15/2022384,800 shares $1.86 million +9.6%4.2%8.6 $4.83 4/30/2022351,000 shares $2.14 million +73.3%3.8%8.6 $6.10 4/15/2022202,600 shares $1.28 million +0.5%2.2%5.7 $6.31 3/31/2022201,700 shares $1.62 million +23.4%2.2%5.9 $8.03 3/15/2022163,400 shares $1.30 million +16.8%1.8%5.2 $7.98 2/28/2022139,900 shares $1.06 million +18.1%1.5%3.9 $7.60 2/15/2022118,500 shares $1.03 million +21.8%1.3%3.3 $8.65 1/31/202297,300 shares $956,459.00 +49.0%1.1%2.7 $9.83 1/15/202265,300 shares $593,577.00 -2.1%0.7%1.8 $9.09 12/31/202166,700 shares $775,721.00 -0.3%0.8%1.9 $11.63 12/15/202166,900 shares $602,100.00 -21.9%0.8%2.1 $9.00 11/30/202185,700 shares $880,996.00 -1.7%0.9%2 $10.28 11/15/202187,200 shares $1.11 million -77.7%0.9%1.9 $12.68 10/29/2021390,900 shares $4.54 million -1.7%4.2%6.2 $11.62 10/15/2021397,600 shares $5.02 million -4.7%4.3%6.3 $12.63 9/30/2021417,000 shares $5.67 million -0.9%4.5%6.2 $13.60 9/15/2021420,800 shares $5.84 million -4.9%4.5%5 $13.87 8/31/2021442,400 shares $6.24 million +3.5%4.6%5.7 $14.10 8/13/2021427,600 shares $5.25 million -1.0%4.5%5.8 $12.28$19 for a FULL YEAR of stock picks?! (Ad)Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.Watch the exclusive AI investor briefing >>> 7/30/2021431,800 shares $5.15 million +0.5%4.3%6.2 $11.92 7/15/2021429,800 shares $5.98 million -4.7%4.3%7 $13.92 6/30/2021451,000 shares $6.76 million +23.0%4.5%6.2 $14.99 6/15/2021366,600 shares $6.14 million +0.2%3.7%5.3 $16.75 5/28/2021365,800 shares $5.21 million +5.0%3.6%4.8 $14.25 5/14/2021348,400 shares $4.32 million +51.1%3.5%4.5 $12.40 4/30/2021230,600 shares $3.87 million +1.9%3.0%3.1 $16.80 4/15/2021226,400 shares $3.78 million +139.3%3.1%3.3 $16.69 3/31/202194,600 shares $1.65 million -12.6%1.4%1.6 $17.42 3/15/2021108,200 shares $2.17 million -15.3%2.0%2.2 $20.02 2/26/2021127,700 shares $2.46 million +4.1%2.4%3.9 $19.24 2/12/2021122,700 shares $2.25 million +12.1%2.3%4.5 $18.35 1/29/2021109,500 shares $1.78 million -4.7%2.1%4.1 $16.28 1/15/2021114,900 shares $1.69 million -3.2%2.2%5 $14.68 12/31/2020118,700 shares $1.43 million -13.1%2.3%6.3 $12.08 12/15/2020136,600 shares $1.76 million +10.2%2.7%10.9 $12.90 11/30/2020124,000 shares $1.83 million -2.7%2.5%11.8 $14.75 10/30/2020140,200 shares $2.03 million -1.7%2.8%7.4 $14.49 10/15/2020142,600 shares $2.12 million +1.3%2.9%5.7 $14.89 XGN Short Interest - Frequently Asked Questions What is Exagen's current short interest? Short interest is the volume of Exagen shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 90,500 shares of XGN short. 0.98% of Exagen's shares are currently sold short. Learn More on Exagen's current short interest. What is a good short interest ratio for Exagen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XGN shares currently have a short interest ratio of 1.0. Learn More on Exagen's short interest ratio. What is a good short interest percentage for Exagen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.98% of Exagen's floating shares are currently sold short. Is Exagen's short interest increasing or decreasing? Exagen saw a increase in short interest in April. As of April 30th, there was short interest totaling 90,500 shares, an increase of 48.8% from the previous total of 60,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Exagen's float size? Exagen currently has issued a total of 21,300,000 shares. Some of Exagen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Exagen currently has a public float of 9,220,000 shares. How does Exagen's short interest compare to its competitors? 0.98% of Exagen's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Exagen: Enhabit, Inc. (3.03%), Auna SA (0.75%), Talkspace, Inc. (3.47%), LifeMD, Inc. (14.78%), Castle Biosciences, Inc. (5.23%), Personalis, Inc. (4.37%), Celcuity Inc. (5.60%), Fortrea Holdings Inc. (9.18%), Viemed Healthcare, Inc. (0.93%), The Oncology Institute, Inc. (4.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Exagen stock? Short selling XGN is an investing strategy that aims to generate trading profit from Exagen as its price is falling. XGN shares are trading up $0.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Exagen? A short squeeze for Exagen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XGN, which in turn drives the price of the stock up even further. How often is Exagen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XGN, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Enhabit Short Interest Auna Short Interest Talkspace Short Interest LifeMD Short Interest Castle Biosciences Short Interest Personalis Short Interest Celcuity Short Interest Fortrea Short Interest Viemed Healthcare Short Interest Oncology Institute Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XGN) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XGN Stock Free XGN Stock Alerts